Sawtooth Solutions, LLC Intellia Therapeutics, Inc. Transaction History

Sawtooth Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$38.49 - $76.21 $129,518 - $256,446	-3,365 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$58.27 - $118.99 $458,876 - $937,046	-7,875 Reduced 70.06%	3,365 $245,000
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $528,284 - $725,421	5,243 Added 87.43%	11,240 $1.33 Million
Q3 2021 Nov 09, 2021	SELL	$132.37 - $176.78 $115,029 - $153,621	-869 Reduced 12.66%	5,997 $804,000
Q2 2021 Sep 01, 2021	SELL	$60.88 - $161.91 $260,201 - $692,003	-4,274 Reduced 38.37%	6,866 $1.11 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $519,012 - $932,195	11,140 New	11,140 $894,000

317

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $835M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.